EarningsQ1 2023 Earnings Report

Vertex Pharmaceuticals (VRTX) Q1 2023 Earnings Report

0 Followers

MX:VRTX Q1 2023 EPS Results

Actual EPS$52.29

Consensus EPS$51.66

Beat/MissBeat by +$0.63

One Year Ago EPS$60.35

Actual Revenue$40.34B

Expected Revenue$40.05B

Beat/MissBeat by +$285.69M

YoY Revenue Growth+13.26%

QuarterQ1 2023

Date05/01/2023

TimeAfter Close

Conference CallMonday, May 1, 2023

MX:VRTX Upcoming Earnings

Vertex Pharmaceuticals's next earnings date is estimated for November 9, 2026, based on past reporting schedules.

MX:VRTX Q1 2023 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 09, 2026	2026 (Q3)	81.78 / -	82.293	―
Aug 03, 2026	2026 (Q2)	81.28 / 81.09	77.493	4.65% (+3.60)
May 04, 2026	2026 (Q1)	72.74 / 76.64	69.606	10.10% (+7.03)
Feb 12, 2026	2025 (Q4)	87.63 / 86.24	68.235	26.38% (+18.00)
Nov 03, 2025	2025 (Q3)	78.40 / 82.29	75.093	9.59% (+7.20)
Aug 06, 2025	2025 (Q2)	73.52 / 77.49	-219.963	135.23% (+297.46)
May 05, 2025	2025 (Q1)	74.01 / 69.61	81.607	-14.71% (-12.00)
Feb 10, 2025	2024 (Q4)	68.85 / 68.23	72.007	-5.24% (-3.77)
Nov 04, 2024	2024 (Q3)	69.91 / 75.09	69.949	7.35% (+5.14)
Aug 01, 2024	2024 (Q2)	-199.32 / -219.96	66.692	-429.82% (-286.65)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed